tweetindex

Afshine Emrani MD FACC @afshineemrani · 04 Sep 2026

5/12 Semaglutide is a potent GLP-1R agonist. Strong key for one lock.Tirzepatide is a dual GIP/GLP-1 agonist. At GLP-1R it is actually a biased agonist: good cAMP signaling, relatively weak β-arrestin pull, less internalization. Plus it hits GIP receptors in fat tissue and brain
679Views
4Likes
0Reposts
1Replies
0Quotes
2Bookmarks

Is that a lot?

1.00×vs this author's median680 views is typical
45Percentile for this authorof 20 recent posts
0.12×vs 100K–1M median5 854 views is typical
0.57%Reachviews ÷ followers
0.74%Engagement rateof viewers reacted

Compare with the benchmark table →

Open on X →